Genetic variations affecting gene expression play a crucial role in breast cancer chemotherapy response. This study investigates how gene expression profiles impact treatment outcomes and explores ...
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing first line tyrosine kinase or checkpoint inhibitor therapy.